Page last updated: 2024-10-28

hydroxyurea and Myelodysplastic-Myeloproliferative Diseases

hydroxyurea has been researched along with Myelodysplastic-Myeloproliferative Diseases in 3 studies

Myelodysplastic-Myeloproliferative Diseases: Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"Secondary thrombocytosis is a frequent secondary finding in childhood infection and inflammation."2.72Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management. ( Cario, H; Duffert, CM; Knöfler, R; Kulozik, AE; Stockklausner, C; Streif, W, 2021)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Mykytiv, V1
Alnajjar, K1
Stockklausner, C1
Duffert, CM1
Cario, H1
Knöfler, R1
Streif, W1
Kulozik, AE1
Curto-Garcia, N1
Harrison, CN1

Reviews

1 review available for hydroxyurea and Myelodysplastic-Myeloproliferative Diseases

ArticleYear
Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.
    Annals of hematology, 2021, Volume: 100, Issue:7

    Topics: Adolescent; Adult; Age of Onset; Algorithms; Anticoagulants; Calreticulin; Child; Disease Management

2021

Other Studies

2 other studies available for hydroxyurea and Myelodysplastic-Myeloproliferative Diseases

ArticleYear
Leukostasis as a result of rapidly progressive granulocytosis in a patient diagnosed with MDS/MPN-U.
    Blood, 2019, 12-05, Volume: 134, Issue:23

    Topics: Aged; Bone Marrow; Fatal Outcome; Hematologic Neoplasms; Humans; Hydroxyurea; Leukostasis; Male; Mye

2019
An updated review of the JAK1/2 inhibitor (ruxolitinib) in the Philadelphia-negative myeloproliferative neoplasms.
    Future oncology (London, England), 2018, Volume: 14, Issue:2

    Topics: Aged; Animals; Blood Cell Count; Clinical Trials, Phase III as Topic; Disease Models, Animal; Diseas

2018